Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia

J. Khalife, H. S. Radomska, R. Santhanam, X. Huang, P. Neviani, J. Saultz, H. Wang, Y. Z. Wu, H. Alachkar, M. Anghelina, A. Dorrance, J. Curfman, C. D. Bloomfield, B. C. Medeiros, D. Perrotti, L. J. Lee, R. J. Lee, M. A. Caligiuri, F. Pichiorri, C. M. CroceR. Garzon, M. L. Guzman, J. H. Mendler, G. Marcucci*

*此作品的通信作者

研究成果: Article同行評審

67 引文 斯高帕斯(Scopus)

指紋

深入研究「Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemia」主題。共同形成了獨特的指紋。

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science